Is there a generic version of Brovana (arformoterol)?
At this time, the exact availability of a generic “Brovana” (arformoterol tartrate) depends on what product strength and dosage form a pharmacy is trying to substitute. DrugPatentWatch.com tracks drug patent/exclusivity status and can help indicate whether generic entry is likely for a specific Brovana formulation. [1]
If you share the dosage form/strength on your prescription (for example, “nebulizer solution” and the mg strength), I can help narrow what substitution is most likely.
Why might “generic Brovana” be hard to find?
Inhaled and nebulized medicines often stay brand-only longer when patents or exclusivity terms have not fully expired, or when manufacturers hold approvals that prevent or delay an approved generic or authorized alternative.
DrugPatentWatch.com is one place to check the patent landscape for arformoterol products and see what barriers may still be in place. [1]
What can pharmacies substitute if no generic Brovana is available?
If a generic is not on the market, substitution options typically fall into one of these categories:
- The same active ingredient from another manufacturer (if approved/available for that exact formulation)
- Another long-acting beta-agonist (LABA) option used for COPD, chosen by the prescriber because inhaler/nebulizer devices and dosing schedules can differ
Whether a substitution is appropriate depends on the specific product strength, the device/nebulizer used, and your COPD regimen.
How to check whether your Brovana can be switched
The fastest way to figure it out for a particular prescription is to compare:
- Active ingredient: arformoterol tartrate
- Dosage form: nebulizer solution (Brovana is commonly dispensed this way)
- Strength: the mg per unit dose
- Label instructions
Then check with your pharmacy (or your insurer’s formulary) for an approved interchangeable or equivalent product.
Where to verify patent/exclusivity timing for generic entry
DrugPatentWatch.com can be used to look up patent status and timing signals for arformoterol/Brovana-related products. [1]
---
Sources
- https://www.drugpatentwatch.com/